You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI

3 Results Found

  • Article
  • Open Access
17 Citations
3,612 Views
11 Pages
Download PDF

Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer Patients

  • Samanta Salvi,
  • Erika Bandini,
  • Silvia Carloni,
  • Valentina Casadio,
  • Michela Battistelli,
  • Sara Salucci,
  • Ilaria Erani,
  • Emanuela Scarpi,
  • Roberta Gunelli and
  • Giacomo Cicchetti
  • + 3 authors
Diagnostics2021, 11(3), 466;https://doi.org/10.3390/diagnostics11030466

8 March 2021

Prostate Cancer (PCa) is one of the most frequently identified urological cancers. PCa patients are often over-diagnosed due to still not highly specific diagnostic methods. The need for more accurate diagnostic tools to prevent overestimated diagnos...

Full Article
  • Article
  • Open Access
28 Citations
4,880 Views
12 Pages
Download PDF

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach

  • Miriana d’Alessandro,
  • Piera Soccio,
  • Laura Bergantini,
  • Paolo Cameli,
  • Giulia Scioscia,
  • Maria Pia Foschino Barbaro,
  • Donato Lacedonia and
  • Elena Bargagli
Cells2021, 10(5), 1045;https://doi.org/10.3390/cells10051045

28 April 2021

Background: Extracellular vesicles (EVs) are secreted by cells from their membrane within circulation and body fluids. Knowledge of the involvement of EVs in pathogenesis of lung diseases is increasing. The present study aimed to evaluate the express...

Full Article
  • Article
  • Open Access
1 Citations
3,051 Views
13 Pages
Download PDF

In-Depth Characterization of L1CAM+ Extracellular Vesicles as Potential Biomarkers for Anti-CD20 Therapy Response in Relapsing–Remitting Multiple Sclerosis

  • Shamundeeswari Anandan,
  • Karina Maciak,
  • Regina Breinbauer,
  • Laura Otero-Ortega,
  • Giancarlo Feliciello,
  • Nataša Stojanović Gužvić,
  • Oivind Torkildsen and
  • Kjell-Morten Myhr
Int. J. Mol. Sci.2025, 26(15), 7213;https://doi.org/10.3390/ijms26157213

25 July 2025

The effective suppression of inflammation using disease-modifying therapies is essential in the treatment of multiple sclerosis (MS). Anti-CD20 monoclonal antibodies are commonly used long-term as maintenance therapies, largely due to the lack of rel...

Full Article